Parathyroid adenoma in the sternocleidomastoid muscle 30 years after thyroidectomy
Annales d'Endocrinologie · 2023
DOI: 10.1016/j.ando.2023.10.002 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annales d'Endocrinologie, 2023. Verfasst von Matthieu Thumerel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Department, Haut Lévêque Hospital, Bordeaux University Hospital and Bordeaux University, avenue de Magellan, 33604 Pessac, Bordeaux,…. Hauptthemen laut MEDLINE: Parathyroid Neoplasms, Adenoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thoracic Surgery Department, Haut Lévêque Hospital, Bordeaux University Hospital and Bordeaux University, avenue de Magellan, 33604 Pessac, Bordeaux, France. Electronic address: matthieu.thumerel@chu-bordeaux.fr.
- Thoracic Surgery Department, Haut Lévêque Hospital, Bordeaux University Hospital and Bordeaux University, avenue de Magellan, 33604 Pessac, Bordeaux, France.
- Endocrinology and Endocrine Oncology Department, Haut Lévêque Hospital, Bordeaux University Hospital and Bordeaux University, avenue de Magellan 33604 Pessac, Bordeaux, France.
Zitieren
APA
Thumerel, M., Belaroussi, Y., McSweeney, J., & Haissaguerre, M. (2023). Parathyroid adenoma in the sternocleidomastoid muscle 30 years after thyroidectomy. Annales d'Endocrinologie. https://doi.org/10.1016/j.ando.2023.10.002
Vancouver
Thumerel M, Belaroussi Y, McSweeney J, Haissaguerre M. Parathyroid adenoma in the sternocleidomastoid muscle 30 years after thyroidectomy. Annales d'Endocrinologie. 2023. doi:10.1016/j.ando.2023.10.002
BibTeX
@article{Thumerel2023,
author = {Thumerel, Matthieu and Belaroussi, Yaniss and McSweeney, Jared and Haissaguerre, Magalie},
title = {Parathyroid adenoma in the sternocleidomastoid muscle 30 years after thyroidectomy},
journal = {Annales d'Endocrinologie},
year = {2023},
doi = {10.1016/j.ando.2023.10.002}
}
EUVIMED